Bionano Genomics (BNGO) Capital Expenditures (2017 - 2024)

Bionano Genomics has disclosed Capital Expenditures across 6 years of filings, most recently posting $77000.0 for Q2 2024.

• Capital Expenditures for Q2 2024 came in at $77000.0, up 161.11% year-over-year; the trailing twelve-month figure through Mar 2025 was $77000.0 (down 94.82% YoY), and the FY2024 annual result was $103000.0, down 93.91% from the prior year.
• Capital Expenditures came in at $77000.0 for Q2 2024 at Bionano Genomics, up from $26000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $842000.0 in Q3 2023 to a low of -$767000.0 in Q4 2022.
• The 3-year median for Capital Expenditures is $153500.0 (2023), against an average of $188400.0.
• Peak annual rise in Capital Expenditures reached 477.58% in 2023, while the deepest fall reached 150.81% in 2023.
• Bionano Genomics' Capital Expenditures stood at -$767000.0 in 2022, then soared by 197.13% to $745000.0 in 2023, then sank by 89.66% to $77000.0 in 2024.
• The last three Capital Expenditures figures came in at $77000.0 (Q2 2024), $26000.0 (Q1 2024), and $745000.0 (Q4 2023), per Business Quant data.